Navigation Links
Delta System

ProductsDelta System
Company Stryker Leibinger Micro Implants
Item Delta System
Features Resorable craniomaxillofacial fixation system provides the option of both Torque-Limited and Direct-Drive Systems. Both types of screws come in a wide range of sizes, 1.5 mm, 2.0 mm, 2.5 mm and 2.8 mm emergency screws. The new Lactosorb SE System offers a unique battery-powered heat pen. Using easily switchable tips, it can be used for both cutting and in-sito shaping of the Lactosorb SE plates and panels. Lactosorb SE offers a choice a variety of specialty plates.
Description 1.7/2.2 mm Delta System resorbable implant technology merges science and simplicity for a superior craniomaxillofacial surgery product. The system consists of resorbable bone plates and screws fabricated from a unique tripolymer.
Info Stryker Leibinger Micro Implants
Customer Service: (269) 324-5346
Web site: http://www.stryker.com/microimplants/

Related medicine products :

1. Synchron CX3 Delta
2. PS Medical® Delta valve
3. Delta Wire Grasper
4. Dornier Compact Delta
5. Ncircle® Nitinol Tipless Stone Extractors with Delta Wire®
6. Deltatrac II Metabolic Monitor
7. SYNCHRON CX® 4 Delta
8. SYNCHRON CX 3 Delta
9. SYNCHRON CX®5 Delta
10. Delta-Aminolevulinic Acid, Urine
11. Delta OD 450
Enzyme Immunoassay of Tissue Plasminogen Activator Antigen by ELISA Method, 96 tests....
Citrated human plasma for the calibration of vWF assays by the immuno-turbidimetric method on STA© analyzers.(STA© Liatest© vWF #0518)....
Heparin-Platelet Factor 4 Induced Antibody...
Control Plasma for Assays of Low MolecularWeight Heparins (LMWH) using Anti-Xa Method on STA© Analyzers....
Medicine Products:
(Date:4/1/2015)... BioPlus Specialty Pharmacy (BioPlus), one ... a new app to keep health care providers informed ... C virus (HCV) infection. This ‘HCV Treatment Path’ app ... American Association for the Study of Liver Diseases (AASLD) ... oral medications to treat HCV have been approved by ...
(Date:4/1/2015)... EAGAN, Minn. (April 1, 2015) —Blue Cross and ... (Blue Cross) today announced audited financial results for 2014. ... of $61.5 million, reflecting positive investment portfolio performance that ... operating loss of $8.2 million on full-year revenues of ... of one percent (0.1%). , Blue Cross reported ...
(Date:4/1/2015)... MD (PRWEB) April 01, 2015 ... free informational seminars in April to discuss the benefits ... for those suffering from periodontal disease. People who ... and suffer from gum disease can now visit Dr. ... to traditional gum surgery. With the LANAP® protocol, which ...
(Date:4/1/2015)... April 01, 2015 Parents of teenaged ... Rehabilitation’s blog, where the latest post discusses Teen Violence ... observation of Teen Dating Violence Awareness Month, the substance ... growing problem to help parents identify if there may ... that might involve drugs or alcohol. , “People learn ...
(Date:4/1/2015)... OSF Saint Paul Medical Center, the ... was welcomed into the Ministry April 1, 2015, with ... E. Showalter, vicar general of the Catholic Diocese of ... a nearly year-long transition process for the former Mendota ... for the morning ceremony included Sister Judith Ann Duvall, ...
Breaking Medicine News(10 mins):Health News:BioPlus Specialty Pharmacy Releases ‘HCV Treatment Path’ App for Hepatitis C Providers 2Health News:Blue Cross and Blue Shield of Minnesota Reports 2014 Results 2Health News:Blue Cross and Blue Shield of Minnesota Reports 2014 Results 3Health News:Dr. Daniel C. Stewart Offers Columbia Area Residents an Informational Seminar in April About Less Invasive Gum Disease Treatment Now Available at Smile Savers Dentistry 2Health News:Dr. Daniel C. Stewart Offers Columbia Area Residents an Informational Seminar in April About Less Invasive Gum Disease Treatment Now Available at Smile Savers Dentistry 3Health News:Best Drug Rehabilitation Issues Toolkit for Teen Violence Related to Substance Abuse 2Health News:Mendota Community Hospital Now OSF Saint Paul Medical Center 2Health News:Mendota Community Hospital Now OSF Saint Paul Medical Center 3
... Jude Childrens Research Hospital study shows that T ... use simple on/off switches to govern the cellular ... they possess sophisticated molecular controls that enable them ... subtle adjustment enables T cells to modulate their ...
... dermatitis, SCHAUMBURG, Ill., May 12 For the ... an important fashion accessory,that many women wear, and change, ... getting more than they bargained for when purchasing,inexpensive earrings. ... dermatitis on the earlobes and repeated exposure can make ...
... to have committed patent and ... trademark ... MTEX ) a leading developer and provider of dietary,supplements and ... the Northern District of Texas found that Glycoproducts,International Inc. had ...
... As part of its,Distinguished Americans series, the U.S. ... that honors Dr. Edward Livingston Trudeau (1848-1915), the,founder ... the Study and,Prevention of Tuberculosis, the precursor to ... to researching and treating tuberculosis, a,highly infectious disease ...
... Occupational and Environmental Medicine, Investigates Relationship of Co-payments, Medication Adherence, ... ... PHILADELPHIA, May 12 High prescription drug,co-payments are associated with ... new study published this month in the,Journal of Occupational and ...
... BOSTON -- In both leukemia and solid tumors, there ... small subgroup that work undercover, patiently lying in wait ... cells (CICs) or leukemia initiating cells (LICs), these stealth ... targeted cancer therapies. When a leukemia patient relapses following ...
Cached Medicine News:Health News:St. Jude study shows how T cell's machinery dials down autoimmunity 2Health News:St. Jude study shows how T cell's machinery dials down autoimmunity 3Health News:Study Finds Nearly One-Third of All Inexpensive Earrings Examined Tested Positive for Nickel 2Health News:Study Finds Nearly One-Third of All Inexpensive Earrings Examined Tested Positive for Nickel 3Health News:Study Finds Nearly One-Third of All Inexpensive Earrings Examined Tested Positive for Nickel 4Health News:Jury Validates Key Mannatech Technology Patents Involving Its Ambrotose(R) Glyconutrient Products 2Health News:Jury Validates Key Mannatech Technology Patents Involving Its Ambrotose(R) Glyconutrient Products 3Health News:American Lung Association Founder Honored With New U.S. Postage Stamp 2Health News:New Study Shows Lowering Co-payments Can Lead to Lower Total Healthcare Costs, Improved Overall Health 2Health News:New Study Shows Lowering Co-payments Can Lead to Lower Total Healthcare Costs, Improved Overall Health 3Health News:New Study Shows Lowering Co-payments Can Lead to Lower Total Healthcare Costs, Improved Overall Health 4Health News:New Study Shows Lowering Co-payments Can Lead to Lower Total Healthcare Costs, Improved Overall Health 5Health News:Arsenic-based therapy shown to help eradicate leukemia-initiating cells 2Health News:Arsenic-based therapy shown to help eradicate leukemia-initiating cells 3
(Date:4/1/2015)... 2015  CryoLife, Inc. (NYSE: CRY ), a ... cardiac and vascular surgery, announced today the appointment of ... Vice President, General Counsel and Corporate Secretary effective April ... Pat Mackin , President and Chief Executive Officer. ... and has extensive legal experience in the medical device ...
(Date:4/1/2015)... , April 1, 2015 Trinity Biotech ... and manufacturer of diagnostic products for the point-of-care ... Biotech Investment Limited, its wholly-owned subsidiary (the "Issuer"), ... considerations, $100 million aggregate principal amount of Exchangeable ... to qualified institutional buyers pursuant to Rule 144A ...
(Date:4/1/2015)... MOUNTAIN VIEW, Calif. , April ... BSX ) announces that it has signed a ... medical device company that develops, manufactures and sells ... transluminal drainage of targeted areas within the gastrointestinal ... week. The Xlumena portfolio includes ...
Breaking Medicine Technology:CryoLife Appoints Jean Holloway as General Counsel 2CryoLife Appoints Jean Holloway as General Counsel 3Trinity Biotech plc Announces Proposed Offering of $100 Million of Exchangeable Senior Notes due 2045 2Trinity Biotech plc Announces Proposed Offering of $100 Million of Exchangeable Senior Notes due 2045 3Trinity Biotech plc Announces Proposed Offering of $100 Million of Exchangeable Senior Notes due 2045 4Boston Scientific Agrees to Acquire Xlumena 2Boston Scientific Agrees to Acquire Xlumena 3Boston Scientific Agrees to Acquire Xlumena 4Boston Scientific Agrees to Acquire Xlumena 5